Clinical Trial Update: Study of BBP-418 in Patients With LGMD2I [Phase 2]

View source ↗

Summary

The document reports a Phase 2 clinical trial of BBP-418 for limb-girdle muscular dystrophy type 2I (LGMD2I), with the study currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-girdle Muscular Dystrophy Type 2i

Drugs mentioned

• BBP-418

Snippet

Sponsor: ML Bio Solutions, Inc. | Conditions: LGMD2I | Phase 2 | Status: ACTIVE_NOT_RECRUITING